Positron emission tomography imaging of dopamine D2/3 receptors in the human cortex with [11C]FLB 457: Reproducibility studies

Synapse

Volumn 65, Issue 1, 2011, Pages 35-40

  Narendran, Rajesh ^a,b   Mason, N Scott ^a   May, Maureen A ^b   Chen, Chi Min ^b   Kendro, Steve ^a   Ridler, Khanum ^c   Rabiner, Eugenii A ^c,d   Laruelle, Marc ^c   Mathis, Chester A ^a   Frankle, W Gordon ^a,b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

11C FLB 457; D2 3 receptors; DA; Human cortex; PET

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ISOREMOXIPRIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; KINETICS; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RELIABILITY; REPRODUCIBILITY; TEST RETEST RELIABILITY;

ANALYSIS OF VARIANCE; CARBON RADIOISOTOPES; CEREBRAL CORTEX; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REPRODUCIBILITY OF RESULTS; SALICYLAMIDES;

EID: 78049392014     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20813     Document Type: Article

References (22)

1. 123I]iomazenil: Kinetic and equilibrium paradigms. J Nucl Med 35: 228-238.
2. 11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 20: 225-243.
3. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M. 2002. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22: 3708-3719.
4. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB. 1994. Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT, IBF and iomazenil. J Pharm Sci 83: 1014-1019.
5. 11C]WAY- 100635 for PET. Neuroimage 8: 426-440.
6. Halldin C, Farde L, Hogberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG. 1995. Carbon-11-FLB 457: A radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 36: 1275-1281.
7. Hill AV. 1910. The possible effects of the aggregation of the molecules of haemoglobin on its disassociation curves. Phys Med Biol 1991: 749-761.
8. 11C[SCH23390]: A test-retest analysis. J Cereb Blood Flow Metab 21: 1146-1150.
9. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
10. Kirk RE. 1982. Experimental design: Procedures for the behavioral sciences. Pacific Grove, California: Brooks/Cole publishing company.
11. Lacerda AL, Hardan AY, Yorbik O, Keshavan MS. 2003. Measurement of the orbitofrontal cortex: A validation study of a new method. Neuroimage 19: 665-673.
12. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15: 217-227.
13. 11C]fallypride. Synapse 63: 447-461.
14. 11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab 19: 1164-1173.
15. 11C]flumazenil: A test-retest study in healthy subjects. NeuroImage 41: 260-269.
16. Smith GS, Price JC, Lopresti BJ, Huang Y, Simpson N, Holt D, Mason NS, Meltzer CC, Sweet RA, Nichols T, Sashin D, Mathis CA. 1998. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse 30: 380-392.
17. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. 2004. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl 1): S208-S219.
18. 11C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 22: 1215-1221.
19. van Velden FH, Kloet RW, van Berckel BN, Buijs FL, Luurtsema G, Lammertsma AA, Boellaard R. 2009. HRRT versus HR+ human brain PET studies: An interscanner test-retest study. J Nucl Med 50: 693-702.
20. 11C]FLB 457-A test-retest analysis. Eur J Nucl Med 27: 1666-1673.
21. 11C-WAY-100635. J Nucl Med 48: 926-931.
22. Zhang Y, Brady M, Smith S. 2001. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57.